NYSE:SNY - Sanofi Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$44.61 -0.98 (-2.15 %)
(As of 11/13/2018 01:42 AM ET)
Previous Close$45.59
Today's Range$44.54 - $45.03
52-Week Range$37.43 - $46.25
Volume727,888 shs
Average Volume1.86 million shs
Market Capitalization$114.34 billion
P/E Ratio14.25
Dividend Yield2.68%
Beta0.7
Sanofi provides therapeutic solutions. It offers Cerezyme and Cerdelga for Gaucher disease, Myozyme and Lumizyme for Pompe disease, Fabrazyme for Fabry disease, and Aldurazyme for mucopolysaccharidosis Type 1; Aubagio, an oral immunomodulatory; and Lemtrada, a monoclonal antibody to treat multiple sclerosis. The company also provides Jevtana, a taxane derivative for prostate cancer; Taxotere, a taxoid for cancers; Eloxatin, a platinum agent for colorectal cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil, a hematopoietic stem cell mobilizer; and Zaltrap, a protein for metastatic colorectal cancer. In addition, it offers Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl, an oral sulfonylurea; Lyxumia/Adlyxin, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; and Praluent, a cholesterol-lowering drug and Multaq, an anti-arrhythmic drug for atrial fibrillation. Further, the company provides Plavix, an anti-platelet agent for atherothrombotic conditions; Lovenox, a heparin for the prophylaxis and venous thromboembolism and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela oral phosphate binders for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; and Allegra, an anti-histamine for seasonal allergic rhinitis and uncomplicated hives. Additionally, it offers consumer health care products and generic medicines; and pediatric, influenza, adult and adolescent booster, meningitis, and travel and endemic vaccines. Sanofi has strategic alliance with Sensile Medical Ltd.; and partnership with REVOLUTION Medicines, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Receive SNY News and Ratings via Email

Sign-up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNYSE:SNY
Previous Symbol
CUSIPN/A
Phone33-1-53-77-44-00

Debt

Debt-to-Equity Ratio0.40
Current Ratio1.22
Quick Ratio0.85

Price-To-Earnings

Trailing P/E Ratio14.25
Forward P/E Ratio14.44
P/E Growth2.58

Sales & Book Value

Annual Sales$39.60 billion
Price / Sales2.83
Cash Flow$4.6712 per share
Price / Cash9.55
Book Value$26.11 per share
Price / Book1.71

Profitability

EPS (Most Recent Fiscal Year)$3.13
Net Income$4.28 billion
Net Margins12.20%
Return on Equity18.18%
Return on Assets9.78%

Miscellaneous

Employees106,566
Outstanding Shares2,508,090,000
Market Cap$114.34 billion
OptionableOptionable

Sanofi (NYSE:SNY) Frequently Asked Questions

What is Sanofi's stock symbol?

Sanofi trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNY."

How often does Sanofi pay dividends? What is the dividend yield for Sanofi?

Sanofi declared an annual dividend on Tuesday, February 13th. Investors of record on Thursday, May 10th will be given a dividend of $1.8609 per share on Monday, June 4th. This represents a yield of 4.72%. The ex-dividend date of this dividend is Wednesday, May 9th. This is a boost from Sanofi's previous annual dividend of $1.58. View Sanofi's Dividend History.

How were Sanofi's earnings last quarter?

Sanofi SA (NYSE:SNY) posted its quarterly earnings results on Wednesday, October, 31st. The company reported $1.07 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.98 by $0.09. The company earned $9.39 billion during the quarter, compared to the consensus estimate of $9.10 billion. Sanofi had a return on equity of 18.18% and a net margin of 12.20%. The business's revenue was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.71 earnings per share. View Sanofi's Earnings History.

When is Sanofi's next earnings date?

Sanofi is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for Sanofi.

What price target have analysts set for SNY?

15 brokers have issued twelve-month price targets for Sanofi's shares. Their predictions range from $45.00 to $55.00. On average, they anticipate Sanofi's stock price to reach $49.50 in the next year. This suggests a possible upside of 11.0% from the stock's current price. View Analyst Price Targets for Sanofi.

What is the consensus analysts' recommendation for Sanofi?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanofi in the last year. There are currently 1 sell rating, 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Sanofi.

Has Sanofi been receiving favorable news coverage?

News stories about SNY stock have trended somewhat positive on Tuesday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sanofi earned a news sentiment score of 1.7 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near term.

Who are some of Sanofi's key competitors?

Who are Sanofi's key executives?

Sanofi's management team includes the folowing people:
  • Mr. Olivier Brandicourt, CEO & Director (Age 62)
  • Mr. Jérôme Contamine, CFO & Exec. VP (Age 61)
  • Mr. Laurent Gilhodes, Principal Accounting Officer and VP of Corp. Accounting
  • Mr. Bruno Ménard, Chief Information officer
  • Mr. George Grofik, Head of Investor Relations

Who are Sanofi's major shareholders?

Sanofi's stock is owned by many different of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (0.62%), FMR LLC (0.34%), BlackRock Inc. (0.12%), Brandes Investment Partners LP (0.11%), Hamlin Capital Management LLC (0.08%) and St. James Investment Company LLC (0.06%). View Institutional Ownership Trends for Sanofi.

Which institutional investors are selling Sanofi stock?

SNY stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, BlackRock Inc., Brandes Investment Partners LP, BB&T Corp, SG Americas Securities LLC, Russell Investments Group Ltd., Hamlin Capital Management LLC and Biechele Royce Advisors. View Insider Buying and Selling for Sanofi.

Which institutional investors are buying Sanofi stock?

SNY stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Alliancebernstein L.P., Bank of New York Mellon Corp, Aperio Group LLC, JPMorgan Chase & Co., Cornerstone Wealth Management LLC, Moody National Bank Trust Division and Crossmark Global Holdings Inc.. View Insider Buying and Selling for Sanofi.

How do I buy shares of Sanofi?

Shares of SNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sanofi's stock price today?

One share of SNY stock can currently be purchased for approximately $44.61.

How big of a company is Sanofi?

Sanofi has a market capitalization of $114.34 billion and generates $39.60 billion in revenue each year. The company earns $4.28 billion in net income (profit) each year or $3.13 on an earnings per share basis. Sanofi employs 106,566 workers across the globe.

What is Sanofi's official website?

The official website for Sanofi is http://www.sanofi.com.

How can I contact Sanofi?

Sanofi's mailing address is 54 RUE LA BOETIE, PARIS I0, 75008. The company can be reached via phone at 33-1-53-77-44-00 or via email at [email protected]


MarketBeat Community Rating for Sanofi (NYSE SNY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  365 (Vote Outperform)
Underperform Votes:  465 (Vote Underperform)
Total Votes:  830
MarketBeat's community ratings are surveys of what our community members think about Sanofi and other stocks. Vote "Outperform" if you believe SNY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel